This observation was consistent regardless of whether the CD8+ T- cell targeted epitopes were from structural or non-structural SARS-CoV-2 protein antigens, suggesting that strong CD8+ T- cell responses specific to selected “universal” SARS-CoV-2 epitopes were commonly associated with better COVID-19 outcomes. Here, CD8A is linked to COVID-19.